Viewing Study NCT03469804


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-02-01 @ 11:22 AM
Study NCT ID: NCT03469804
Status: UNKNOWN
Last Update Posted: 2019-10-21
First Post: 2018-03-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kaposi Sarcoma View
None Progression, Disease View
Keywords: